Distinct expression profiles of lncRNAs between early-onset preeclampsia and preterm controls

Clin Chim Acta. 2016 Dec 1:463:193-199. doi: 10.1016/j.cca.2016.10.036. Epub 2016 Nov 2.

Abstract

Early-onset preeclampsia (EOPE), which is the most severe form of the syndrome, confers a high risk of neonatal morbidity and perinatal death. We aim to study the roles of long non-coding RNAs (lncRNAs) in the pathogenesis of early-onset preeclampsia (EOPE). Therefore, we examined the expression profiles of lncRNAs between early-onset preeclampsia and preterm controls using microarray analysis. Quantitative real-time PCR (qRT-PCR) was performed to verify the selected differentially expressed lncRNAs. In total, we identified 15,646 upregulated and 13,178 downregulated lncRNAs in the placenta of EOPE patients compared to the preterm controls. Gene ontology and pathway analysis revealed that compared to the preterm controls, many of the processes over-represented in the EOPE patients were related to cell migration and cell motility. A selection of the differentially expressed lncRNA transcripts was confirmed using qRT-PCR, particularly RP11-465L10.10, which is associated with the MMP9 gene. These data may offer a background/reference resource for future functional studies of lncRNAs related to EOPE.

Keywords: Early-onset preeclampsia; LncRNA; MMP9; Microarray; Real-time PCR.

MeSH terms

  • Case-Control Studies
  • Down-Regulation
  • Female
  • Humans
  • Oligonucleotide Array Sequence Analysis
  • Pre-Eclampsia / genetics*
  • Pre-Eclampsia / metabolism
  • Pregnancy
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / metabolism
  • Real-Time Polymerase Chain Reaction
  • Transcriptome*
  • Up-Regulation

Substances

  • RNA, Long Noncoding